Literature DB >> 24903339

Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features.

Chinatsu Arima1, Taisuke Kajino1, Yoshinori Tamada2, Seiya Imoto2, Yukako Shimada1, Masahiro Nakatochi3, Motoshi Suzuki1, Hisanori Isomura1, Yasushi Yatabe4, Tomoya Yamaguchi1, Kiyoshi Yanagisawa1, Satoru Miyano2, Takashi Takahashi5.   

Abstract

Accumulation of genetic and epigenetic changes alters regulation of a web of interconnected genes including microRNAs (miRNAs), which confer hallmark capabilities and characteristic cancer features. In this study, the miRNA and messenger RNA expression profiles of 126 non-small cell lung cancer specimens were analyzed, with special attention given to the diversity of lung adenocarcinomas. Of those, 76 adenocarcinomas were classified into two major subtypes, developing lung-like and adult lung-like, based on their distinctive miRNA expression profiles resembling those of either developing or adult lungs, respectively. A systems biology-based approach using a Bayesian network and non-parametric regression was employed to estimate the gene regulatory circuitry functioning in patient tumors in order to identify subnetworks enriched for genes with differential expression between the two major subtypes. miR-30d and miR-195, identified as hub genes in such subnetworks, had lower levels of expression in the developing lung-like subtype, whereas introduction of miR-30d or miR-195 into the lung cancer cell lines evoked shifts of messenger RNA expression profiles toward the adult lung-like subtype. Conversely, the influence of miR-30d and miR-195 was significantly different between the developing lung-like and adult lung-like subtypes in our analysis of the patient data set. In addition, RRM2, a child gene of the miR-30d-centered subnetwork, was found to be a direct target of miR-30d. Together, our findings reveal the existence of two miRNA expression profile-defined lung adenocarcinoma subtypes with distinctive clinicopathologic features and also suggest the usefulness of a systems biology-based approach to gain insight into the altered regulatory circuitry involved in cancer development.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903339     DOI: 10.1093/carcin/bgu127

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; Xiuye Ma; Alexander Pertsemlidis
Journal:  Cancer Lett       Date:  2018-04-13       Impact factor: 8.679

2.  Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.

Authors:  Dong-Yao Li; Wen-Jie Chen; Jun Shang; Gang Chen; Shi-Kang Li
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

Review 3.  State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan.

Authors:  Yung-Hung Luo; Kung-Hao Liang; Hsu-Ching Huang; Chia-I Shen; Chi-Lu Chiang; Mong-Lien Wang; Shih-Hwa Chiou; Yuh-Min Chen
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

4.  Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.

Authors:  Motoshi Suzuki; Ke Cao; Seiichi Kato; Yuji Komizu; Naoki Mizutani; Kouji Tanaka; Chinatsu Arima; Mei Chee Tai; Kiyoshi Yanagisawa; Norie Togawa; Takahiro Shiraishi; Noriyasu Usami; Tetsuo Taniguchi; Takayuki Fukui; Kohei Yokoi; Keiko Wakahara; Yoshinori Hasegawa; Yukiko Mizutani; Yasuyuki Igarashi; Jin-ichi Inokuchi; Soichiro Iwaki; Satoshi Fujii; Akira Satou; Yoko Matsumoto; Ryuichi Ueoka; Keiko Tamiya-Koizumi; Takashi Murate; Mitsuhiro Nakamura; Mamoru Kyogashima; Takashi Takahashi
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

5.  miR‑200b upregulation promotes migration of BEAS‑2B cells following long‑term exposure to cigarette smoke by targeting ETS1.

Authors:  Jin Wang; Ruixin Yao; Qiulin Luo; Lirong Tan; Beibei Jia; Nan Ouyang; Yezhou Li; Jian Tong; Jianxiang Li
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

6.  A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.

Authors:  Jaume Forés-Martos; Raimundo Cervera-Vidal; Enrique Chirivella; Alberto Ramos-Jarero; Joan Climent
Journal:  Front Physiol       Date:  2015-02-04       Impact factor: 4.566

7.  The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.

Authors:  Anlin Feng; Zhenbo Tu; Bingjiao Yin
Journal:  Oncotarget       Date:  2016-04-12

8.  Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer.

Authors:  Fengfeng Wang; Fei Meng; Lili Wang; S C Cesar Wong; William C S Cho; Lawrence W C Chan
Journal:  Front Genet       Date:  2016-10-13       Impact factor: 4.599

9.  MicroRNA-383-5p acts as a prognostic marker and inhibitor of cell proliferation in lung adenocarcinoma by cancerous inhibitor of protein phosphatase 2A.

Authors:  Shasha Zhao; Xinyuan Gao; Shuzhi Zang; Yunxia Li; Xianjun Feng; Xiaomei Yuan
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

10.  MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.

Authors:  Yong-Qiang Zhang; Wei-Ya Wang; Jian-Xin Xue; Yan Xu; Ping Fan; Bennett Adam Caughey; Wei-Wei Tan; Gui-Qun Cao; Li-Li Jiang; You Lu; Kang Zhang; Xun Hu
Journal:  J Cancer       Date:  2016-07-18       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.